- Home
- BGMS vs HSCS Comparison
BGMS vs HSCS Comparison
Compare BGMS & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BGMS | HSCS |
|---|---|---|
| Founded | 1996 | 2007 |
| Country | Malaysia | United States |
| Employees | 19 | 12 |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8M | 6.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BGMS | HSCS |
|---|---|---|
| Price | $1.01 | $1.77 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | ★ 61.6K | 21.0K |
| Earning Date | 05-08-2026 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $80,482.35 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.73 | $1.80 |
| 52 Week High | $6.70 | $6.47 |
Technical Indicators
Market Signals| Indicator | BGMS | HSCS |
|---|---|---|
| Relative Strength Index (RSI) | 51.32 | 34.05 |
| Support Level | $0.89 | N/A |
| Resistance Level | $1.13 | $2.19 |
| Average True Range (ATR) | 0.08 | 0.14 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 50.00 | 0.00 |
Price Performance
Historical ComparisonAbout BGMS Bio Green Med Solution Inc.
Bio Green Med Solution Inc is engaged in the supply and trading of protective and fire safety equipment. The company distributes products such as fire extinguishers, foam systems, fire-resistant doors, personal protective equipment, and safety apparel. It also provides fire safety systems, including sprinkler systems, fire alarm systems, valves, and CO2 systems. The company operates across commercial, industrial, healthcare, and residential sectors, with a focus on distribution and compliance with applicable safety standards.
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.